Business Insider
My Markets Watchlist
Markets Stocks

Kenvue Inc Registered Shs Stock , KVUE

21.45 -0.22 -0.99%
03:59:59 PM BTT
News Analyst Data Analyst Opinions Insider Activity Dividend Calendar

On Tuesday 06/17/2025 the closing price of the Kenvue Inc Registered Shs share was $21.45 on BTT. Compared to the opening price on Tuesday 06/17/2025 on BTT of $21.63, this is a drop of 0.84%. Kenvue Inc Registered Shs's market capitalization is $33.77 B by 1.92 B shares outstanding.

Kenvue Stock Snapshot

21.37
Bid
2.00
Bid Size
21.51
Ask
100.00
Ask Size
6/17/2025
Date
3:59 PM
Time
448,159.00
Volume
21.66
Prev. Close
21.63
Open
41.56 B
Market Cap in USD
1.92 B
Number of Shares
1.92 B
Total Number of Shares
21.42
Day Low
21.79
Day High
21.45
17.67
52 Week Low
25.17
52 Week High
21.45
0.81
Dividend in USD
3.79
Dividend Yield
39.67
P/E Ratio
99.93
Free Float in %
0.54
EPS in USD
5.05
Book Value per Share in USD
0.92
Cash Flow per Share in USD

Historical Prices for Kenvue

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

Kenvue Analyst Data

Total Analysts: 31
Buy Ratings: 13 Neutral Ratings: 16 Sell Ratings: 2
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price *Price Target
Lowest: 18.00 Median: 23.60 Highest: 29.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

Kenvue Analyst Opinions

  • All
  • Buy
  • Hold
  • Sell
Date Analyst Rating Price
05/12/25 Barclays Capital
Maintained Hold $23
05/09/25 UBS
Maintained Hold $25
05/09/25 Citigroup Corp.
Maintained Hold $24.5
04/14/25 Citigroup Corp.
Maintained Hold $22
04/14/25 Barclays Capital
Maintained Hold $22
03/27/25 Barclays Capital
Maintained Hold $23
03/24/25 Evercore
Maintained Hold $25
03/05/25 Capital Depesche
Maintained Buy $29
02/24/25 Piper Sandler
Maintained Buy $27
02/07/25 Capital Depesche
Maintained Buy $24
02/07/25 UBS
Maintained Hold $21
02/03/25 RBC Capital Markets
Maintained Hold $24
07/25/24 Deutsche Bank
Maintained Buy $23
07/22/24 J.P. Morgan
Maintained Buy $22
07/10/24 Citigroup Corp.
Maintained Hold $20
05/28/24 Citigroup Corp.
Maintained Hold $21
05/08/24 HSBC
Maintained Sell $21
04/11/24 Bernstein
Maintained Sell $18
04/03/24 William Blair
Maintained Hold
03/04/24 Goldman Sachs
Maintained Hold $20
03/01/24 Goldman Sachs
Downgraded to Hold $20
02/13/24 RBC Capital Markets
Maintained Buy $24
02/09/24 J.P. Morgan
Maintained Buy $24
02/09/24 RBC Capital Markets
Maintained Buy $24
12/19/23 UBS
Maintained Hold $23
11/17/23 Piper Sandler
Maintained Hold $20
10/10/23 Goldman Sachs
Maintained Buy $26
10/04/23 J.P. Morgan
Maintained Buy $26
09/11/23 Deutsche Bank
Upgraded to Buy $27
09/07/23 Capital Depesche
Maintained Buy $28
09/06/23 Argus Research Company
Maintained Hold
08/24/23 Goldman Sachs
Upgraded to Buy $29
07/25/23 Edward Jones
Maintained Buy
07/21/23 Citigroup Corp.
Maintained Hold $26

Kenvue Estimates* in USD

  2025 2026 2027 2028 2029
Revenue 15,588 16,121 16,647 17,355 17,953
Dividend 0.82 0.84 0.85 0.89 0.96
Dividend Yield (in %) 3.78 % 3.90 % 3.95 % 4.12 % 4.42 %
EPS 1.14 1.22 1.30 1.41 1.49
P/E Ratio 19.03 17.75 16.66 15.41 14.53
EBIT 3,339 3,550 3,709 3,955 4,092
EBITDA 3,670 3,936 4,125 4,409 4,491
Net Profit 2,192 2,358 2,497 2,683 2,765
Net Profit Adjusted 2,193 2,358 2,485 2,683 2,765
Pre-Tax Profit 2,987 3,189 3,306 3,374 3,712
Pre-Tax Profit Reported 2,558 2,925 3,102 3,309 3,486
EPS (Non-GAAP) ex. SOE 1.14 1.22 1.30 1.41 -
EPS (GAAP) 0.97 1.14 1.18 1.27 1.39
Gross Income 9,358 9,682 10,075 - -
Cash Flow from Investing -450 -464 -453 - -
Cash Flow from Operations 2,728 3,139 3,462 4,383 -
Cash Flow from Financing -1,809 -1,871 -1,944 - -
Cash Flow per Share 1.29 1.52 1.58 1.74 1.90
Free Cash Flow 1,826 2,456 2,683 2,607 -
Free Cash Flow per Share 0.99 1.30 1.37 1.45 -
Book Value per Share 5.35 5.69 6.24 6.16 6.42
Net Debt 6,877 6,270 5,621 5,164 5,537
Research & Development Exp. 406 414 420 - -
Capital Expenditure 530 457 465 455 487
Selling, General & Admin. Exp. 5,959 6,110 6,148 - -
Shareholder’s Equity 10,007 10,492 11,166 11,717 11,909
Total Assets 25,888 26,269 26,735 - -
  Previous Quarter
ending 03/31/25 		Current Quarter
ending 06/30/25 		Next Quarter
ending 09/30/25 		Current Year
ending 12/31/25 		Next Year
ending 12/31/26
Earnings Estimates
No. of Analysts - 12 12 15 16
Average Estimate - 0.280 USD 0.316 USD 1.138 USD 1.221 USD
Year Ago - 0.030 USD 0.200 USD 0.538 USD -
Publish Date - 7/17/2025 10/23/2025 - -
Revenue Estimates
No. of Analysts - 11 11 14 14
Average Estimate - 3,944 USD 4,032 USD 15,588 USD 16,121 USD
Year Ago - 4,000 USD 3,900 USD 15,456 USD -
Publish Date - 7/17/2025 10/23/2025 - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. USD

2024 2023 2022 2021 2020 2019
Sales 15,456.00 15,443.00 14,929.00 15,043.00 14,469.00 14,317.00
Change of sales in % 0.08 3.44 -0.76 3.97 1.06 -
Gross profit on sales 8,972.00 8,612.00 8,307.00 8,479.00 7,887.00 7,691.00
Gross profit on sales change in % 4.18 3.67 -2.03 7.51 2.55 -
Operating income 2,652.00 2,939.00 2,719.00 3,063.00 2,979.00 2,541.00
Operating income change in % -9.77 8.09 -11.23 2.82 17.24 -
Income before tax 1,415.00 2,190.00 2,637.00 2,925.00 -1,016.00 2,120.00
Income before tax change in % -35.39 -16.95 -9.85 - - -
Income after tax 1,030.00 1,664.00 2,087.00 2,031.00 -879.00 1,435.00
Income after tax change in % -38.10 -20.27 2.76 - - -

Balance Sheet in Mio. USD

2024 2023 2022 2021 2020 2019
Total liabilities 15,933.00 16,640.00 7,295.00 7,530.00 10,821.00 -
Long-term liabilities per share 5.33 5.83 1.78 1.85 1.76 -
Equity 9,668.00 11,211.00 20,021.00 20,399.00 18,356.00 -
Equity change in % -13.76 -44.00 -1.85 11.13 - -
Balance sheet total 25,601.00 27,851.00 27,316.00 27,929.00 29,177.00 -
Balance sheet total change in % -8.08 1.96 -2.19 -4.28 - -

Key Data in USD

2024 2023 2022 2021 2020 2019
Sales per share 8.08 8.06 7.90 7.96 7.66 7.58
P/E ratio (year end quote, basic EPS) 39.67 24.78 - - - -
P/E ratio (year end quote, diluted EPS) 39.67 24.78 - - - -
Dividend yield in % 3.79 1.86 - - - -
Equity ratio in % 37.76 40.25 73.29 73.04 62.91 -
Debt ratio in % 62.24 59.75 26.71 26.96 37.09 -

Kenvue Insider Activity

Name Date shares traded shares held Price type (sell/buy) option
Dyer Russell 06/02/2025 965.00 1,704.15 22.21 Sell No
Dyer Russell 06/02/2025 2,669.15 2,669.15 n/a Buy No
Lawson Carlton 03/12/2025 17,100.00 56,316.03 23.03 Sell No
Xie Bing 03/04/2025 3,085.00 47,603.12 23.04 Sell No
Tavares Bernardo 03/04/2025 580.00 14,001.65 23.04 Sell No
Xie Bing 03/04/2025 6,169.00 50,688.12 n/a Buy No
Tavares Bernardo 03/04/2025 1,502.65 14,581.65 n/a Buy No
England Charmaine 02/13/2025 1,721.00 22,484.00 21.75 Sell No
England Charmaine 02/13/2025 4,300.00 27,496.00 21.75 Sell No
Ruh Paul 02/13/2025 2,854.00 37,031.69 21.75 Sell No
Meurer Jan 02/13/2025 1,661.00 21,361.45 21.75 Sell No
Meurer Jan 02/13/2025 4,169.00 28,764.45 21.75 Sell No
Ruh Paul 02/13/2025 7,216.00 52,573.69 21.75 Sell No
England Charmaine 02/13/2025 9,312.00 31,796.00 n/a Buy No
England Charmaine 02/13/2025 3,726.00 24,205.00 n/a Buy No
Ruh Paul 02/13/2025 22,758.00 59,789.69 n/a Buy No
Ruh Paul 02/13/2025 9,105.00 39,885.69 n/a Buy No
Meurer Jan 02/13/2025 11,572.00 32,933.45 n/a Buy No
Meurer Jan 02/13/2025 4,630.00 23,022.45 n/a Buy No
England Charmaine 02/12/2025 596.00 20,479.00 21.23 Sell No
Howlett Heather 02/12/2025 575.00 1,969.00 21.23 Sell No
Meurer Jan 02/12/2025 879.00 18,392.45 21.23 Sell No
Ruh Paul 02/12/2025 815.00 30,780.69 21.23 Sell No
England Charmaine 02/12/2025 1,289.00 21,075.00 n/a Buy No
Howlett Heather 02/12/2025 1,556.00 2,544.00 n/a Buy No

Kenvue Dividend Calendar

Date Name Dividend *yield Currency
2024 Kenvue Inc Registered Shs 0.81 3.79 USD
2023 Kenvue Inc Registered Shs 0.40 1.86 USD
2022 Kenvue Inc Registered Shs - - USD
2021 Kenvue Inc Registered Shs - - USD
2020 Kenvue Inc Registered Shs - - USD
2019 Kenvue Inc Registered Shs - - USD
*Yield of the Respective Date

Kenvue Calendar

Event Estimate Info Date
Earnings Report 0.280 USD Q2 2025 Earnings Release 07/17/2025
Earnings Report 0.316 USD Q3 2025 Earnings Release 10/23/2025
Earnings Report 0.293 USD Q4 2025 Earnings Release 02/05/2026
Earnings Report 0.274 USD Q1 2026 Earnings Release 05/13/2026

Kenvue Past Events

Event Actual EPS Info Date
Annual General Meeting 0.540 USD Annual General Meeting 05/22/2025
Earnings Report 0.170 USD Q1 2025 Earnings Release 05/08/2025
Earnings Report 0.150 USD Q4 2024 Earnings Release 02/06/2025
Earnings Report 0.200 USD Q3 2024 Earnings Release 11/07/2024
Earnings Report 0.030 USD Q2 2024 Earnings Release 08/06/2024
Annual General Meeting 0.900 USD Annual General Meeting 05/23/2024
Earnings Report 0.150 USD Q1 2024 Earnings Release 05/07/2024
Earnings Report 0.170 USD Q4 2023 Earnings Release 02/08/2024
Earnings Report 0.229 USD Q3 2023 Earnings Release 10/26/2023
Earnings Report 0.225 USD Q2 2023 Earnings Release 07/20/2023

Kenvue Profile

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.